APA aipamena

Bauer, T. M., El-Rayes, B. F., Li, X., Hammad, N., Philip, P. A., Shields, A. F., . . . Bekaii-Saab, T. (2012). Carbohydrate Antigen 19-9 Is a Prognostic and Predictive Biomarker in Patients With Advanced Pancreatic Cancer Who Receive Gemcitabine-Containing Chemotherapy: A Pooled Analysis of 6 Prospective Trials. Cancer.

Chicago Style aipamena

Bauer, Todd M., Bassel F. El-Rayes, Xiaobai Li, Nazik Hammad, Philip A. Philip, Anthony F. Shields, Mark M. Zalupski, and Tanios Bekaii-Saab. "Carbohydrate Antigen 19-9 Is a Prognostic and Predictive Biomarker in Patients With Advanced Pancreatic Cancer Who Receive Gemcitabine-Containing Chemotherapy: A Pooled Analysis of 6 Prospective Trials." Cancer 2012.

MLA aipamena

Bauer, Todd M., et al. "Carbohydrate Antigen 19-9 Is a Prognostic and Predictive Biomarker in Patients With Advanced Pancreatic Cancer Who Receive Gemcitabine-Containing Chemotherapy: A Pooled Analysis of 6 Prospective Trials." Cancer 2012.